GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $361 | +4.9% | 9,960 | +3.1% | 0.08% | +9.6% |
Q2 2023 | $344 | +3.9% | 9,660 | +3.9% | 0.07% | -1.4% |
Q1 2023 | $331 | +22.6% | 9,300 | +21.2% | 0.07% | +12.1% |
Q4 2022 | $270 | -99.8% | 7,675 | +43.7% | 0.07% | +61.0% |
Q3 2022 | $157,000 | -53.0% | 5,340 | -30.4% | 0.04% | -51.8% |
Q2 2022 | $334,000 | -22.3% | 7,671 | -21.4% | 0.08% | -2.3% |
Q4 2021 | $430,000 | +6.2% | 9,762 | -8.0% | 0.09% | -1.1% |
Q3 2021 | $405,000 | -6.7% | 10,611 | -2.6% | 0.09% | -8.3% |
Q2 2021 | $434,000 | -5.0% | 10,896 | -14.9% | 0.10% | +15.7% |
Q1 2021 | $457,000 | -23.5% | 12,798 | -21.1% | 0.08% | -30.8% |
Q4 2020 | $597,000 | +1.4% | 16,216 | +3.7% | 0.12% | -11.1% |
Q3 2020 | $589,000 | -11.8% | 15,643 | -4.4% | 0.14% | -15.6% |
Q2 2020 | $668,000 | +23.2% | 16,366 | +14.5% | 0.16% | +19.4% |
Q1 2020 | $542,000 | -92.4% | 14,291 | -6.4% | 0.13% | -22.5% |
Q4 2019 | $7,174,000 | +1000.3% | 15,266 | 0.0% | 0.17% | +1.8% |
Q3 2019 | $652,000 | +6.7% | 15,266 | +0.0% | 0.17% | +5.6% |
Q2 2019 | $611,000 | -17.0% | 15,260 | -13.3% | 0.16% | -17.9% |
Q1 2019 | $736,000 | +26.5% | 17,610 | +15.6% | 0.20% | +10.7% |
Q4 2018 | $582,000 | -4.3% | 15,230 | +0.7% | 0.18% | +11.3% |
Q3 2018 | $608,000 | -7.9% | 15,130 | -7.6% | 0.16% | -17.2% |
Q2 2018 | $660,000 | +3.1% | 16,380 | 0.0% | 0.19% | +2.1% |
Q1 2018 | $640,000 | +15.5% | 16,380 | +4.8% | 0.19% | +18.2% |
Q4 2017 | $554,000 | -37.9% | 15,630 | -28.8% | 0.16% | -42.0% |
Q3 2017 | $892,000 | -1.1% | 21,965 | +4.9% | 0.27% | -5.8% |
Q2 2017 | $902,000 | +27.2% | 20,940 | +24.4% | 0.29% | +22.8% |
Q1 2017 | $709,000 | +23.7% | 16,835 | +13.1% | 0.24% | +22.8% |
Q4 2016 | $573,000 | -17.1% | 14,885 | -7.1% | 0.19% | -20.2% |
Q3 2016 | $691,000 | +22.3% | 16,017 | +22.8% | 0.24% | +20.4% |
Q2 2016 | $565,000 | -51.1% | 13,042 | -54.4% | 0.20% | -9.5% |
Q1 2016 | $1,155,000 | +98.1% | 28,574 | +97.6% | 0.22% | -5.1% |
Q4 2015 | $583,000 | +17.1% | 14,457 | +11.6% | 0.23% | +15.3% |
Q3 2015 | $498,000 | -21.5% | 12,952 | -15.0% | 0.20% | -15.8% |
Q2 2015 | $634,000 | -9.4% | 15,245 | +0.4% | 0.24% | -8.4% |
Q1 2015 | $700,000 | +30.4% | 15,177 | +20.9% | 0.26% | +27.1% |
Q4 2014 | $537,000 | +16.5% | 12,557 | +25.2% | 0.21% | +11.3% |
Q3 2014 | $461,000 | -14.8% | 10,027 | -0.9% | 0.19% | -15.1% |
Q2 2014 | $541,000 | +8.4% | 10,117 | +8.4% | 0.22% | +0.9% |
Q1 2014 | $499,000 | +4.4% | 9,332 | +4.2% | 0.22% | +2.8% |
Q4 2013 | $478,000 | – | 8,952 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |